These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 3113753)

  • 1. The binding efficiency of polyclonal and monoclonal antibodies to DNA modified with benzo[a]pyrene diol epoxide is dependent on the level of modification. Implications for quantitation of benzo[a]pyrene-DNA adducts in vivo.
    Van Schooten FJ; Kriek E; Steenwinkel MJ; Noteborn HP; Hillebrand MJ; Van Leeuwen FE
    Carcinogenesis; 1987 Sep; 8(9):1263-9. PubMed ID: 3113753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interlaboratory comparison of antisera and immunoassays for benzo[a]pyrene-diol-epoxide-I-modified DNA.
    Santella RM; Weston A; Perera FP; Trivers GT; Harris CC; Young TL; Nguyen D; Lee BM; Poirier MC
    Carcinogenesis; 1988 Jul; 9(7):1265-9. PubMed ID: 3133129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoaffinity chromatography of carcinogen DNA adducts with polyclonal antibodies directed against benzo[a]pyrene diol-epoxide-DNA.
    Tierney B; Benson A; Garner RC
    J Natl Cancer Inst; 1986 Jul; 77(1):261-7. PubMed ID: 3459918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to DNA modified by a benzo[a]pyrene diol epoxide.
    Santella RM; Lin CD; Cleveland WL; Weinstein IB
    Carcinogenesis; 1984 Mar; 5(3):373-7. PubMed ID: 6423306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding efficiency of antibodies to DNA modified with aromatic amines and polycyclic aromatic hydrocarbons: implications for quantification of carcinogen-DNA adducts in vivo.
    Kriek E; Van Schooten FJ; Hillebrand MJ; Welling MC
    IARC Sci Publ; 1988; (89):201-7. PubMed ID: 3143670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High selectivity of polyclonal antibodies against DNA modified by diastereomeric benzo[c]phenanthrene-3,4-diol-1,2-epoxides.
    Butch ER; Lau HH; Shaw KL; Smolarek TA; Schmerold I; Anderson JN; Baird WM; Yagi H; Jerina DM
    Carcinogenesis; 1992 May; 13(5):895-9. PubMed ID: 1587005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of optimal conditions for the detection of benzo[a]pyrene-DNA adducts by enzyme-linked immunoadsorbent assays (ELISA).
    Bucci F; Galati R; Zito R; Falasca G; Federico A; Verdina A
    Anticancer Res; 1998; 18(4A):2669-74. PubMed ID: 9703926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of stereospecificity of benzo[a]pyrene diolepoxide-DNA antisera with site-specifically modified oligonucleotides.
    Hsu TM; Liu TM; Amin S; Geacintov NE; Santella RM
    Carcinogenesis; 1995 Sep; 16(9):2263-5. PubMed ID: 7554088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of exposure to benzo[a]pyrene with monoclonal antibodies.
    Santella RM; Hsieh LL; Lin CD; Viet S; Weinstein IB
    Environ Health Perspect; 1985 Oct; 62():95-9. PubMed ID: 4085452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo formation and persistence of DNA adducts in mouse and rat skin exposed to (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene and (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.
    Rojas M; Alexandrov K
    Carcinogenesis; 1986 Sep; 7(9):1553-60. PubMed ID: 3091285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential recognition of stereochemically defined base adducts by antibodies against anti-benzo[a]pyrene diol-epoxide-modified DNA.
    Venkatachalam S; Wani AA
    Carcinogenesis; 1994 Apr; 15(4):565-72. PubMed ID: 8149464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA repair in human cells: quantitative assessment of bulky anti-BPDE-DNA adducts by non-competitive immunoassays.
    Venkatachalam S; Denissenko M; Wani AA
    Carcinogenesis; 1995 Sep; 16(9):2029-36. PubMed ID: 7554050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical visualization of DNA adducts in mouse tissues and human white blood cells following treatment with benzo[a]pyrene or its diol epoxide. A quantitative approach.
    van Schooten FJ; Hillebrand MJ; Scherer E; den Engelse L; Kriek E
    Carcinogenesis; 1991 Mar; 12(3):427-33. PubMed ID: 1901249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of 32P-postlabelling and immunological methods to examine human lung DNA for benzo[a]pyrene adducts.
    Garner RC; Tierney B; Phillips DH
    IARC Sci Publ; 1988; (89):196-200. PubMed ID: 3143669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzo(a)pyrene diol epoxide-I-DNA adduct formation in the epidermis and lung of SENCAR mice following topical application of crude coal tar.
    Mukhtar H; Asokan P; Das M; Santella RM; Bickers DR
    Cancer Lett; 1986 Dec; 33(3):287-94. PubMed ID: 3100019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of DNA and globin adducts of polynuclear aromatic hydrocarbon diol epoxides by gas chromatography-mass spectrometry and -3H-CH3I postlabeling of released tetraols.
    Melikian AA; Sun P; Coleman S; Amin S; Hecht SS
    Chem Res Toxicol; 1996 Mar; 9(2):508-16. PubMed ID: 8839056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative study of stereospecific binding of monoclonal antibody to anti-benzo(a)pyrene diol epoxide-N(2)-dG adducts by capillary electrophoresis immunoassay.
    Wang C; Li T; Wang Z; Feng F; Wang H
    J Chromatogr A; 2010 Apr; 1217(15):2254-61. PubMed ID: 20223464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectral differentiation and immunoaffinity capillary electrophoresis separation of enantiomeric benzo(a)pyrene diol epoxide-derived DNA adducts.
    Miksa B; Chinnappan R; Dang NC; Reppert M; Matter B; Tretyakova N; Grubor NM; Jankowiak R
    Chem Res Toxicol; 2007 Aug; 20(8):1192-9. PubMed ID: 17630708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
    Ginsberg GL; Atherholt TB
    Cancer Res; 1990 Feb; 50(4):1189-94. PubMed ID: 2105163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and quantitative detection of isomeric benzo[a]pyrene diolepoxide--DNA adducts by low-temperature conventional fluorescence methods.
    Zhao R; Liu TM; Kim SK; MacLeod MC; Geacintov NE
    Carcinogenesis; 1992 Oct; 13(10):1817-24. PubMed ID: 1423840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.